The dawn of targeted therapy for primary myelofibrosis: Opportunities and challenges

Ruben A. Mesa

doi:10.1016/j.leukres.2007.01.001

The dawn of targeted therapy for primary myelofibrosis: Opportunities and challenges

Ruben A. Mesa

Hematology/Oncology

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	883-886
Number of pages	4
Journal	Leukemia Research
Volume	31
Issue number	7
DOIs	https://doi.org/10.1016/j.leukres.2007.01.001
State	Published - Jul 2007

Keywords

JAK2
Myeloproliferative disorders
PTK 787
Primary myelofibrosis
VEGF

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1016/j.leukres.2007.01.001

Cite this

@article{71e71bbc559743a399c16c65b2cc19d0,

title = "The dawn of targeted therapy for primary myelofibrosis: Opportunities and challenges",

keywords = "JAK2, Myeloproliferative disorders, PTK 787, Primary myelofibrosis, VEGF",

author = "Mesa, {Ruben A.}",

year = "2007",

month = jul,

doi = "10.1016/j.leukres.2007.01.001",

language = "English (US)",

volume = "31",

pages = "883--886",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Limited",

number = "7",

}

TY - JOUR

T1 - The dawn of targeted therapy for primary myelofibrosis

T2 - Opportunities and challenges

AU - Mesa, Ruben A.

PY - 2007/7

Y1 - 2007/7

KW - JAK2

KW - Myeloproliferative disorders

KW - PTK 787

KW - Primary myelofibrosis

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=34249786248&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249786248&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2007.01.001

DO - 10.1016/j.leukres.2007.01.001

M3 - Editorial

C2 - 17303238

AN - SCOPUS:34249786248

SN - 0145-2126

VL - 31

SP - 883

EP - 886

JO - Leukemia Research

JF - Leukemia Research

IS - 7

ER -

The dawn of targeted therapy for primary myelofibrosis: Opportunities and challenges

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this